Common Contracts
13 similar Investors Rights Agreement contracts by Arcadia Biosciences, Inc., AeroGrow International, Inc., ARCA Biopharma, Inc., others
INVESTORS RIGHTS AGREEMENTInvestors Rights Agreement • August 29th, 2024 • Tesseract Collective, Inc. • Finance services • Delaware
THIS INVESTORS RIGHTS AGREEMENT (this “Agreement”), is made as of October 10, 2023, by and among Tesseract Collective, Inc., a Delaware corporation, dba Tesseract Icons (the “Company”), and Homebase Ltd., a Bahamian limited corporation (“Homebase”), as listed on Schedule A hereto and referred to in this Agreement as an “Investor”.
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 14th, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of March 6, 2024, by and among Oruka Therapeutics, Inc. a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the securityholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder”.
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • January 14th, 2022 • Good Earth Organics, Inc. • Agricultural production-crops • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of January 7, 2022, by and among The Good Earth Organics, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
VENTYX BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT September 9, 2021Investors’ Rights Agreement • September 29th, 2021 • Ventyx Biosciences, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of September 9, 2021, by and among Ventyx Bioscience, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor.”
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 16th, 2020 • Lantern Pharma Inc. • Pharmaceutical preparations • Texas
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as March 17, 2017, by and among Lantern Pharma Inc., a Texas corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.8 hereof.
H-CYTE, INC. INVESTORS' RIGHTS AGREEMENT Dated as of November 15, 2019 INVESTORS' RIGHTS AGREEMENTInvestors' Rights Agreement • February 25th, 2020 • FWHC Holdings, LLC • Surgical & medical instruments & apparatus • Nevada
This INVESTORS' RIGHTS AGREEMENT is made and entered into as of the 15th day of November, 2019, by and among H-CYTE, INC., a Nevada corporation (the "Company") and each of the investors listed on Schedule I hereto (the "Investors").
H-CYTE, INC. INVESTORS’ RIGHTS AGREEMENT Dated as of November 15, 2019 INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • November 21st, 2019 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • Nevada
This INVESTORS’ RIGHTS AGREEMENT is made and entered into as of the 15th day of November, 2019, by and among H-CYTE, INC., a Nevada corporation (the “Company”) and each of the investors listed on Schedule I hereto (the “Investors”).
INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • December 14th, 2017 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of __________, 2015, by and among Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Company”), each of the investors signatory hereto as of the date hereof (each an “Investor”) and each Investor that becomes a party to this Agreement in accordance with Section 6.8 hereof.
ARCADIA BIOSCIENCES, INC. INVESTORS’ RIGHTS AGREEMENT March 28, 2014Investors’ Rights Agreement • February 17th, 2015 • Arcadia Biosciences, Inc. • Agricultural chemicals • Arizona
THIS INVESTORS’ RIGHTS AGREEMENT is made as of the 28th day of March 2014, by and among Arcadia Biosciences, Inc., an Arizona corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
ARCADIA BIOSCIENCES, INC. INVESTORS’ RIGHTS AGREEMENT March 28, 2014Investors’ Rights Agreement • December 22nd, 2014 • Arcadia Biosciences, Inc. • Agricultural chemicals • Arizona
THIS INVESTORS’ RIGHTS AGREEMENT is made as of the 28th day of March 2014, by and among Arcadia Biosciences, Inc., an Arizona corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
INVESTOR’S RIGHTS AGREEMENT by and between AEROGROW INTERNATIONAL, INC. and SMG GROWING MEDIA, INC. dated as of April 22, 2013Investor's Rights Agreement • April 23rd, 2013 • AeroGrow International, Inc. • Retail-building materials, hardware, garden supply • Nevada
THIS INVESTOR’S RIGHTS AGREEMENT is made as of the 22nd day of April, 2013 (this “Agreement”), by and among AeroGrow International, Inc., a Nevada corporation (the “Company”), and SMG Growing Media, Inc., an Ohio corporation (the “Investor”).
INVESTORS’ RIGHTS AGREEMENTInvestors' Rights Agreement • February 13th, 2012 • R&r Acquisition Vi, Inc • Blank checks • New York
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 13th, 2009 • Diligent Board Member Services, Inc. • Services-prepackaged software • New York
